Neutral
Why Lucid Diagnostics Inc. (LUCD) Faced a Price Target Reduction After Q1 Results
Maxim Group reduced its price target on Lucid Diagnostics Inc. (NASDAQ:LUCD) from $3 to $2, while maintaining a Buy rating, following the company's we...